Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 6.1x - 6.8x | 6.5x |
| Selected Fwd Ps Multiple | 4.2x - 4.7x | 4.5x |
| Fair Value | ¥2.97 - ¥3.28 | ¥3.13 |
| Upside | -35.4% - -28.6% | -32.0% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Jiangxi Fushine Pharmaceutical Co., Ltd. | 30,049,700.0% | SZSE:300497 |
| Ji Yao Holding Group Co., Ltd. | 30,010,800.0% | SZSE:300108 |
| Hunan Hansen Pharmaceutical Co., Ltd. | 241,200.0% | SZSE:002412 |
| Shandong Sinobioway Biomedicine Co., Ltd. | 258,100.0% | SZSE:002581 |
| Fujian Cosunter Pharmaceutical Co., Ltd. | 30,043,600.0% | SZSE:300436 |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 90,800.0% | SZSE:000908 |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| 300497 | 300108 | 2412 | 2581 | 300436 | 908 | |||
| SZSE:300497 | SZSE:300108 | SZSE:002412 | SZSE:002581 | SZSE:300436 | SZSE:000908 | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | 6.7% | -18.2% | 0.7% | -8.3% | 1.0% | -24.0% | ||
| 3Y CAGR | 2.5% | -18.9% | 8.8% | 15.8% | 4.7% | -9.2% | ||
| Latest Twelve Months | -23.6% | 4.2% | 5.0% | -3.3% | 27.5% | -49.2% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 2.5% | -112.3% | 17.8% | -11.4% | -27.5% | -66.7% | ||
| Prior Fiscal Year | -8.6% | -56.4% | 18.3% | -4.1% | -33.0% | -14.6% | ||
| Latest Fiscal Year | -12.5% | -100.9% | 21.5% | -77.4% | -82.5% | -32.8% | ||
| Latest Twelve Months | -13.9% | -120.3% | 23.4% | -85.6% | -47.6% | -71.9% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 857.9x | -10.6x | 7.1x | -128.5x | -233.0x | -39.8x | ||
| Price / LTM Sales | 3.3x | 1.8x | 3.3x | 15.9x | 11.0x | 10.0x | ||
| LTM P/E Ratio | -24.0x | -1.5x | 14.0x | -18.6x | -23.2x | -13.8x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 1.8x | 3.3x | 15.9x | |||||
| Historical LTM P/S Ratio | 1.6x | 3.2x | 7.7x | |||||
| Selected Price / Sales Multiple | 6.1x | 6.5x | 6.8x | |||||
| (x) LTM Sales | 398 | 398 | 398 | |||||
| (=) Equity Value | 2,444 | 2,573 | 2,701 | |||||
| (/) Shares Outstanding | 879.8 | 879.8 | 879.8 | |||||
| Implied Value Range | 2.78 | 2.92 | 3.07 | |||||
| FX Rate: CNY/CNY | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 2.78 | 2.92 | 3.07 | 4.60 | ||||
| Upside / (Downside) | -39.6% | -36.4% | -33.3% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 300497 | 300108 | 2412 | 2581 | 300436 | 908 | |
| Value of Common Equity | 4,331 | 659 | 3,170 | 6,439 | 5,144 | 4,047 | |
| (/) Shares Outstanding | 538.6 | 666.0 | 503.2 | 659.7 | 159.3 | 879.8 | |
| Implied Stock Price | 8.04 | 0.99 | 6.30 | 9.76 | 32.30 | 4.60 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 8.04 | 0.99 | 6.30 | 9.76 | 32.30 | 4.60 | |
| Trading Currency | CNY | CNY | CNY | CNY | CNY | CNY | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |